Below, you can conveniently login to multiple products under the Outcomes suite of solutions.
Join a diverse team where your unique perspective can make a difference everyday.
HIMSS 2026 signals a shift for payers toward real-time, coordinated action, with interoperability and pharmacy playing key roles in the future model.
CMS’s CY 2027 proposed rule reshapes Star Ratings, while CY 2026 final rules tighten prior auth and Part D requirements. See impacts for payers and pharmacies.
How payers can succeed in 2026 by investing in clinical pharmacy programs, modern technology, and connected care that improves outcomes and member experience.
During Diabetes Awareness Month, Outcomes unites pharmacists, payers, and manufacturers to close care gaps and improve outcomes for people with diabetes.
The Final Rule was released on April 4, 2024 detailing updates to criteria utilized for MTM Program enrollment effective January 1, 2025.
Here are three clinical areas that payers and their pharmacy care partners will need to emphasize in 2024.
The proposed rule is a detailed outline of all changes and provisions that CMS proposes to make to the Medicare Advantage program in 2025 and beyond.
Let's discuss the issue of nonadherence and what payers can do to improve these numbers and help more patients.
Formulary management can result in significant savings for health plans and combat rises in prescription drug prices.
In this blog, we will discuss how Outcomes has collaborated with CaringWire.
Pharmacists are emerging as pivotal players in healthcare. They have the opportunity to provide care that expands their impact beyond dispensing meds.
There’s opportunity for pharmacists to help avoid the medication errors that occur during a patient's transition of care.